First FDA Clearance of a 2009 H1N1 Test Given to Quest Diagnostics' Focus Diagnostics Business (PR Newswire)
Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510 clearance to the Simplexaâ„¢ Influenza A H1N1 test on the 3Mâ„¢ Integrated Cycler. us.rd.yahoo.com |
PPD and Furiex Announce Completion of Spin-Off (Business Wire)
WILMINGTON, N.C. & MORRISVILLE, N.C.----PPD, Inc. and Furiex Pharmaceuticals, Inc. announced today the successful completion of the spin-off of Furiex. As previously announced, PPD received a private letter ruling from the Internal Revenue Service that the dividend of common stock of Furiex to PPD shareholders qualifies as a tax-free distribution for U.S. income tax purposes. us.rd.yahoo.com |
Psychemedics Corporation Announces Second Quarter Profits (PR Newswire)
Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2010. Â The Company also announced a quarterly dividend of $0.12 per share payable to shareholders of record as of September 3, 2010 to be paid on September 17, 2010. Â This will be the Company's 56th consecutive quarterly dividend. us.rd.yahoo.com |
Employers Raise Workers' Share of Health Costs
Employers passed health-insurance costs onto employees at a sharply higher rate this year, and businesses' premiums grew more slowly than they have in a decade, according to an annual survey. online.wsj.com |
FDA Seeks Data on Arena Obesity Drug
The FDA said it can't approve Arena's locaserin obesity drug because of potential safety risks. Arena plans to work with the FDA to fix the issues. online.wsj.com |